Signaling Pathways in Cancer Pathogenesis and Therapy

Nonfiction, Health & Well Being, Medical, Medical Science, Pharmacology, Specialties, Oncology
Cover of the book Signaling Pathways in Cancer Pathogenesis and Therapy by , Springer New York
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9781461412168
Publisher: Springer New York Publication: November 12, 2011
Imprint: Springer Language: English
Author:
ISBN: 9781461412168
Publisher: Springer New York
Publication: November 12, 2011
Imprint: Springer
Language: English

In recent years, increasing evidence has suggested that abnormal activation of signaling pathways is a critical event in cancer pathogenesis. In particular, activation of these pathways can lead to inappropriate cellular survival, proliferation, pluripotency, invasion, metastasis, and angiogenesis. Thus, understanding the mechanisms by which signaling pathways become subverted in a cancer cell can provide insight into critical events in cancer pathogenesis. Furthermore, as our ability to target specific molecular interactions advances, we now have the ability to design small molecules, protein therapeutics, and other forms of targeted therapies. By focusing on the specific molecular abnormalities in a cancer cell, these agents hold the potential to be much more effective and much less toxic than current cytotoxic therapies.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

In recent years, increasing evidence has suggested that abnormal activation of signaling pathways is a critical event in cancer pathogenesis. In particular, activation of these pathways can lead to inappropriate cellular survival, proliferation, pluripotency, invasion, metastasis, and angiogenesis. Thus, understanding the mechanisms by which signaling pathways become subverted in a cancer cell can provide insight into critical events in cancer pathogenesis. Furthermore, as our ability to target specific molecular interactions advances, we now have the ability to design small molecules, protein therapeutics, and other forms of targeted therapies. By focusing on the specific molecular abnormalities in a cancer cell, these agents hold the potential to be much more effective and much less toxic than current cytotoxic therapies.

More books from Springer New York

Cover of the book Anal and Rectal Diseases by
Cover of the book Understanding and Using the Controller Area Network Communication Protocol by
Cover of the book E-Government Strategy, ICT and Innovation for Citizen Engagement by
Cover of the book Archaeologies of Mobility and Movement by
Cover of the book Probability Approximations and Beyond by
Cover of the book Handbook of Bioenergy Economics and Policy by
Cover of the book Molecular Modeling and Multiscaling Issues for Electronic Material Applications by
Cover of the book Atlas of Endocrine Pathology by
Cover of the book Psychosocial Scenarios for Pediatrics by
Cover of the book Transatlantic Science and Technology by
Cover of the book Consumer Informatics by
Cover of the book Trace Elements in Terrestrial Environments by
Cover of the book Brownian Dynamics at Boundaries and Interfaces by
Cover of the book The Ethics of Cultural Heritage by
Cover of the book Borderline Personality and Mood Disorders by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy